DrugMapper
  • Browse
    • Therapeutic Area
      • CANCER (51)
      • CARDIOVASCULAR (45)
      • DENTISTRY (2)
      • DERMATOLOGY (31)
      • DIABETES DRUGS & ENDOCRINOLOGY (61)
      • EMERGENCY MEDICINE (3)
      • ENT (5)
      • EYE (23)
      • GASTROINTESTINAL (29)
      • HEMATOLOGY (23)
      • MUSCULOSKELETAL (28)
      • NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
      • PEDIATRICS (27)
      • PHARMACOLOGY (8)
      • PREGNANCY AND GYNECOLOGY (30)
      • RESPIRATORY (42)
      • RHEUMATOLOGY (19)
      • OTHER (1482)
    • Therapeutic Indication
    • Adverse Reaction (System Organ Classification)
    • Mechanism of Action
    • Primary Target
    • Target Level
      • Level 1
      • Level 2
      • Level 3
      • Level 4
      • Level 5
      • Level 6
    • Active Pharmaceutical Ingredients (APIs)
    • Small Molecules
    • ProDrugs
    • Antibodies
    • CNS drugs
    • Metabolites
  • Search
      Therapeutic Indication Adverse Reaction (System Organ Classification)
      Mechanism of Action Target Sequence
      Chemical Structure Physicochemical Properties
  • Analyze

      Networks

    • Chemical Similarity
    • Scaffold Similarity
    • KNIME workflow
  • Downloads
      Web services Bulk Downloads
  • About
      DrugMapper FAQs Data Sources Contact Us

FIBROBLAST GROWTH FACTOR-1

Search structure
Synonyms:
ACIDIC FIBROBLAST GROWTH FACTOR
BF-FIBROBLAST GROWTH FACTOR
BIO-FD&C AFGF
ENDOTHELIAL CELL GROWTH FACTOR
FGF-1
FIBROBLAST GROWTH FACTOR 1
HBGF-1
HEPARIN-BINDING GROWTH FACTOR 1
HUMAN FIBROBLAST GROWTH FACTOR 1
HUMAN OLIGOPEPTIDE-13
NEXPURE BIO AFGF
RH-POLYPEPTIDE-11
SH-POLYPEPTIDE-11
VEXXON-AFGF
Status: Phase 1
Entry Type: Unknown
Molecule Category: UNKNOWN
UNII: G53298VN9Y

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Diabetic Foot 1 D017719 ClinicalTrials
Parkinson Disease 1 D010300 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297954
FDA SRS G53298VN9Y
CONTENTS
  • Structure
  • Indications
  • Cross References
×
70